Биология ва тиббиёт муаммолари 2025, №3.1 (162)
Subject of the article
СУРУНКАЛИ ЮРАК ЕТИШМОВЧИЛИГИ НЕГИЗИДА СУРУНКАЛИ БУЙРАК КАСАЛЛИГИ РИВОЖЛАНИШИДА ОКСИДАТИВ СТРЕСС АҲАМИЯТИ (254-256)
Authors
Джураева Нозима Орифовна, Холов Ғуломжон Аҳмадович
Institution
Бухоро давлат тиббиёт институти, Ўзбекистон Республикаси, Бухоро ш.
Abstract
Мақолада сурункали юрак етишмовчилиги негизида сурункали буйрак касаллиги ривожланиши патогенезида оксидловчи стресснинг муҳим роли тўғрисидаги ҳозирги тадқиқот маълумотлари келтирилган. Оксидатив стресс тушунчасининг таърифи, шунингдек унинг зарарли таъсир механизмлари тасвирланган. Оксидловчи ва антиоксидант тизимларнинг умумий хусусиятлари берилган.
Key words
оксидатив стресс, сурункали буйрак касаллиги, сурункали юрак етишмовчилиги, антиоксидант тизим, супероксид дисмутаза.
Literature
1. Арутюнов, Г.П. Патофизиологические процессы в почках у больных ХСН. Журнал сердечная недостаточность. 2008;9(5): 234-249.; 2. Sies, H. Oxidative stress: Oxidants and antioxidants. Exp. Physiol. 1997, 82, 291–295. 3. Hafstad, A.D.; Nabeebaccus, A.A.; Shah, A.M. Novel aspects of ROS signalling in heart failure. Basic Res. Cardiol. 2013, 108, 359.;Sirker, A.; Zhang, M.; Shah, A.M. NADPH oxidases in cardiovascular disease: Insights from in vivo models and clinical studies. Basic Res. Cardiol.2011, 106, 735–747. 4. Modlinger, P.S.; Wilcox, C.S.; Aslam, S. Nitric oxide, oxidative stress, and progression of chronic renal failure. WB Saunders. Semin. Nephrol. 2004, 24, 354–365. 5. Maack, C.; Böhm, M. Targeting mitochondrial oxidative stress in heart failure. Throttling the afterburner. J. Am. Coll. Cardiol. 2011, 58, 83–86. 6. Chen, L.; Knowlton, A.A. Mitochondrial dynamics in heart failure. Congest. Heart Fail 2010, 17, 257–261. 7. Beer, M.; Seyfarth, T.; Sandstede, J.; Landschütz, W.; Lipke, C.; Köstler, H.; von Kienlin, M.; Harre, K.; Hahn, D.; Neubauer, S. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. J. Am. Coll. Cardiol. 2002, 40, 1267–1274.; 8. Kato, T.; Niizuma, S.; Inuzuka, Y.; Kawashima, T.; Okuda, J.; Tamaki, Y.; Iwanaga, Y.; Narazaki, M.; Matsuda, T.; Soga, T.; et al. Analysis of metabolic remod-eling in compensated left ventricular hypertrophy and heart failure. Circ. Heart Fail 2010, 3, 420–430.; 9. Nagase, M. Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome. Clin. Exp. Nephrol. 2010, 14, 303–314. 10. Zou, A.P.; Li, N.; Cowley, A.W. Production and actions of superoxide in the renal medulla. Hypertension 2001, 37, 547–553.; 11. López, B.; Salom, M.G.; Arregui, B.; Valero, F.; Fenoy, F.J. Role of superoxide in modulating the renal effects of angiotensin II. Hypertension 2003, 42, 1150–1156.; 12. Raij, L. Nitric oxide and cardiovascular and renal effects.Osteoarthr.Cartil.2008, 16, S21–S26. 13. Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: acomparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD(SOD3) gene structures, evolution, and expression. Free Radic BiolMed. 2002;33:337–349. 14. Alcaino H, Greig D, Chiong M, Verdejo H, Miranda R, Concepcion R, Vukasovic JL, Diaz-Araya G, Mellado R, Garcia L, et al. Serum uric acidcorrelates with extracellular superoxide dismutase activity in patientswith chronic heart failure. Eur J Heart Fail. 2008;10:646–651. 15. Rababa’h AM, Guillory AN, Mustafa R, Hijjawi T. Oxidative stress and cardiac remodeling: an updated edge. CurrCardiol Rev. 2018;14:53–59